Not provided
Not provided
Not provided
Not provided
Not provided
RECRUITMENT DIFFICULTIES
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims at evaluating clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation.
Secondary outcomes are : 1) to describe the incidence and risk factors of arterial and venous thrombosis in women undergoing assisted reproductive technology and 2)to identify the incidence and risk factors for ovarian hyperstimulation syndrome in these women
All women undergoing an assisted reproductive tecnology in order to receive an in vitro fertilization in French centers will be included in the study. These women will be followed up until 12 months after ovarian stimulation if they get pregnant or until 3 months if the stimulation does not lead to pregnancy. Risk factors for thrombosis and ovarian hyperstimulation syndrome will be collected in each woman. At each visit, women will be asked whether arterial and/or venous thrombosis had occured.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Women undergoing ART | Observation of the incidence of venous and arterial thrombosis following ovarian stimulation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| ovarian stimulation | Other | evaluation of clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Evaluation of professional clinical practice for ovarian stimulation care | Until 12 months followin ovarian stimulation |
| Measure | Description | Time Frame |
|---|---|---|
| Arterial and/or venous thrombosis | until 12 months following ovarian stimulation | |
| Risk factors for thrombosis | until 12 months following ovarian stimulation |
| Measure | Description | Time Frame |
|---|---|---|
| Incidence and risk factors for ovarian hyperstimuation syndrome | until 12 months following ovarian stimulation |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Women undergoing assisted reproductive thechnology
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clinique Pasteur | Brest | 29200 | France | |||
| Medicentre- Clinique du Val d'Ouest |
Not provided
| ID | Term |
|---|---|
| D016471 | Ovarian Hyperstimulation Syndrome |
| D002318 | Cardiovascular Diseases |
| D016769 | Embolism and Thrombosis |
| ID | Term |
|---|---|
| D010049 | Ovarian Diseases |
| D000291 | Adnexal Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D010062 | Ovulation Induction |
| ID | Term |
|---|---|
| D027724 | Reproductive Techniques, Assisted |
| D012099 | Reproductive Techniques |
| D013812 | Therapeutics |
| D008919 | Investigative Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
One blood sample for each women particpating in the study
| Écully |
| 69130 |
| France |
| SELARL Gynecologia | Grenoble | 38000 | France |
| Hôpital Saint Joseph | Marseille | 13001 | France |
| CHU de Nice - Hôpital de l'Archet | Nice | 06202 | France |
| AP-HP - Hôpital Bichat | Paris | 75018 | France |
| Clinique Multualiste La sagesse | Rennes | 35000 | France |
| Clinique Mathilde | Rouen | 76100 | France |
| CHU de Strasbourg - CMCO | Schiltigheine | 67300 | France |
| D005261 |
| Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D006058 | Gonadal Disorders |
| D004700 | Endocrine System Diseases |
| D014652 | Vascular Diseases |